• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Study: Pay-for-Performance Did Not Reduce Deaths in Medicare Pilot Program

Article

A large Medicare pilot program that paid hospitals more if they consistently administered certain medications and vaccinations, provided appropriate counseling for people with heart conditions, or hit other quality targets did not reduce the number of patients who died within 30 days of admission to the hospital, a study published online Wednesday by the New England Journal of Medicine found.

The results are “sobering,” the authors wrote. The program served as a model for a major national initiative being rolled out this year.

Read the full story: http://hcp.lv/Hy9nO4

Source: Boston.com/The Boston Globe

Related Videos
Philip Mease, MD
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Eleanor Perfetto, PhD
Tom Kim, chief medical officer, Sound Long-Term Care Management
Ciara Zachary, PhD, MPH
William Schpero, PhD, MPhil, MPH
Jonathan Strober, MD, Benioff Children's Hospital
Related Content
Flat Medicare Advantage payments in 2027 may push higher costs and fewer benefits onto seniors despite CMS reforms. | Image Credit: Postmodern Studio - stock.adobe.com.jpeg

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

January 27th 2026
Article

CMS’s 2027 proposed MA payment rate increase of .09% falls short of expectations, potentially increasing premiums and reducing benefits for seniors.

Read More

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

Transparency in Coverage Data to Expose Ghost Rates and Hold Payers Accountable: David Muhlestein, PhD

January 20th 2026
Podcast

David Muhlestein, PhD, breaks down ghost rates, data gaps, and why stronger oversight is needed to make Transparency in Coverage files usable for patients.

Listen

Socioeconomic and demographic factors were associated with variations in surgical outcomes among patients with upper extremity soft tissue sarcoma. | Image credit: @syahrir-adobestock.jpeg

Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma

January 22nd 2026
Article

Socioeconomic and demographic factors influenced amputation and recurrence rates in upper extremity soft tissue sarcoma.

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

As ACA subsidy extensions face uncertainty, ICHRAs are gaining attention. Here’s what employers and employees should know. | Image credit: @dragonstock_AdobeStock.jpeg

5 FAQs About ICHRAs: What to Know as ACA Subsidy Extensions Stall

January 16th 2026
Article

With ACA subsidies in limbo, ICHRAs may reshape how Americans access coverage. Here are 5 FAQs explaining what they are, who benefits, and key trade-offs.

Read More

President Trump’s proposed Great Healthcare Plan promises to lower health care costs for Americans if Congress enacts it. | Image credit: Rawf8 - stock.adobe.com

Trump Announces “The Great Healthcare Plan,” Proposing Direct Payments, Price Transparency, Insurance Reform

January 15th 2026
Article

Trump's Great Healthcare Plan aims to lower drug prices, reduce insurance premiums, and enhance transparency, according to the White House.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.